MARI — Marinomed Biotech AG Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMicro CapSucker Stock
- €56.06m
- €69.56m
- €11.63m
Annual cashflow statement for Marinomed Biotech AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.38 | -12.1 | -7.22 | -6.01 | -5.89 |
| Depreciation | |||||
| Non-Cash Items | 0.145 | 6.65 | 1.82 | 0.443 | 1.58 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.152 | 0.893 | -2.57 | -1.75 | -1.17 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.18 | -4.32 | -7.64 | -6.88 | -4.87 |
| Capital Expenditures | -0.154 | -0.229 | -2.34 | -3.96 | -0.919 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | -0.035 | 0 | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.154 | -0.229 | -2.38 | -3.96 | -0.919 |
| Financing Cash Flow Items | 0 | -0.002 | -1.83 | -0.012 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.36 | 0.23 | 20.3 | 8.01 | 2.38 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.02 | -4.31 | 10.3 | -2.81 | -3.4 |